Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Xu, Xiyan"" wg kryterium: Autor


Tytuł:
Update: Influenza Activity in the United States During the 2018-19 Season and Composition of the 2019-20 Influenza Vaccine.
Autorzy:
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kondor R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Nyanseor S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Jun 21; Vol. 68 (24), pp. 544-551. Date of Electronic Publication: 2019 Jun 21.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Cost of Illness ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/administration & dosage ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.
Autorzy:
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Abd Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Reed C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Rolfes M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2019 Feb 15; Vol. 68 (6), pp. 125-134. Date of Electronic Publication: 2019 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Prevalence ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity in the United States During the 2017-18 Season and Composition of the 2018-19 Influenza Vaccine.
Autorzy:
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Biggerstaff M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Jun 08; Vol. 67 (22), pp. 634-642. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; Severity of Illness Index ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity - United States, October 1, 2017-February 3, 2018.
Autorzy:
Budd AP; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2018 Feb 16; Vol. 67 (6), pp. 169-179. Date of Electronic Publication: 2018 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Ambulatory Care/statistics & numerical data ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity - United States, October 1-November 25, 2017.
Autorzy:
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis T; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
O'Halloran A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Dec 08; Vol. 66 (48), pp. 1318-1326. Date of Electronic Publication: 2017 Dec 08.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Outbreaks*
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/epidemiology ; Pneumonia/mortality ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity - United States and Worldwide, May 21-September 23, 2017.
Autorzy:
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan VG; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Grohskopf LA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Lindstrom S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Olsen SJ; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Roguski K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Trock S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Oct 06; Vol. 66 (39), pp. 1043-1051. Date of Electronic Publication: 2017 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Outbreaks*
Population Surveillance*
Global Health/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Centers for Disease Control and Prevention, U.S. ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/genetics ; Seasons ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine.
Autorzy:
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Taylor C; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Chung J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Flannery B; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AIA; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Dugan V; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Jun 30; Vol. 66 (25), pp. 668-676. Date of Electronic Publication: 2017 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Coinfection ; Drug Resistance, Viral ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant Mortality ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/drug effects ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H7N2 Subtype/drug effects ; Influenza A Virus, H7N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza Vaccines/chemistry ; Influenza, Human/mortality ; Influenza, Human/prevention & control ; Influenza, Human/virology ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Update: Influenza Activity - United States, October 2, 2016-February 4, 2017.
Autorzy:
Blanton L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Mustaquim D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Alabi N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kniss K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Kramer N; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Budd A; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garg S; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Cummings CN; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Fry AM; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Bresee J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Sessions W; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Garten R; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Xu X; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Elal AI; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Gubareva L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Barnes J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Burns E; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Katz J; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Jernigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2017 Feb 17; Vol. 66 (6), pp. 159-166. Date of Electronic Publication: 2017 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Population Surveillance*
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza A Virus, H1N2 Subtype/*isolation & purification
Influenza A Virus, H3N2 Subtype/*isolation & purification
Influenza A Virus, H7N2 Subtype/*isolation & purification
Influenza B virus/*isolation & purification
Influenza, Human/*epidemiology
Adolescent ; Adult ; Aged ; Antiviral Agents/pharmacology ; Child ; Child Mortality ; Child, Preschool ; Drug Resistance, Viral ; Female ; Hospitalization/statistics & numerical data ; Humans ; Infant ; Infant, Newborn ; Influenza A Virus, H1N1 Subtype/drug effects ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/drug effects ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza B virus/drug effects ; Influenza B virus/genetics ; Influenza, Human/mortality ; Influenza, Human/virology ; Male ; Middle Aged ; Outpatients/statistics & numerical data ; Pneumonia/mortality ; Pregnancy ; Seasons ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
Autorzy:
Okomo-Adhiambo M; Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sleeman K
Lysén C
Nguyen HT
Xu X
Li Y
Klimov AI
Gubareva LV
Pokaż więcej
Źródło:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2013 Sep; Vol. 7 (5), pp. 645-58. Date of Electronic Publication: 2013 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Viral*
Antiviral Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Influenza A Virus, H1N1 Subtype/*drug effects
Influenza A Virus, H3N2 Subtype/*drug effects
Influenza B virus/*drug effects
Influenza, Human/*virology
Neuraminidase/*antagonists & inhibitors
Acids, Carbocyclic ; Africa ; Cyclopentanes/pharmacology ; Global Health ; Guanidines/pharmacology ; Humans ; Influenza A Virus, H1N1 Subtype/genetics ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A Virus, H3N2 Subtype/isolation & purification ; Influenza B virus/genetics ; Influenza B virus/isolation & purification ; Influenza, Human/drug therapy ; Oceania ; Oseltamivir/pharmacology ; Pyrans ; Seasons ; Sentinel Surveillance ; Sialic Acids ; South America ; Zanamivir/analogs & derivatives ; Zanamivir/pharmacology
Czasopismo naukowe
Tytuł:
Estimated incidence of influenza-virus-associated severe pneumonia in children in El Salvador, 2008-2010.
Autorzy:
Clara W; Centers for Disease Control and Prevention, Central American Region (CDC-CAR), Embassy of the United States in San Salvador El Salvador, Final Blvd Santa Elena, Antiguo Cuscatlan, La Libertad, El Salvador. />Armero J
Rodriguez D
de Lozano C
Bonilla L
Minaya P
Chacón R
Jara J
Blanco N
Widdowson MA
Bresee J
Xu X
Klimov A
Azziz-Baumgartner E
Linares-Perez N
Pokaż więcej
Źródło:
Bulletin of the World Health Organization [Bull World Health Organ] 2012 Oct 01; Vol. 90 (10), pp. 756-63. Date of Electronic Publication: 2012 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype/*isolation & purification
Influenza, Human/*epidemiology
Pneumonia, Viral/*epidemiology
Child, Preschool ; El Salvador/epidemiology ; Female ; Humans ; Incidence ; Infant ; Influenza A Virus, H1N1 Subtype/pathogenicity ; Influenza, Human/complications ; Influenza, Human/virology ; Male ; Mucus/virology ; Pneumonia, Viral/etiology ; Pneumonia, Viral/virology ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Molecular epidemiology of influenza A(H1N1)pdm09 viruses from Pakistan in 2009-2010.
Autorzy:
Bashir Aamir U; Department of Virology, Public Health Laboratories Division, National Institute of Health, Chak Shahzad, Islamabad, Pakistan.
Badar N
Mehmood MR
Nisar N
Suleman RM
Shaukat S
Sharif S
Kamran J
Zaidi SS
Kazi BM
Gubareva L
Xu X
Garten R
Klimov A
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (8), pp. e41866. Date of Electronic Publication: 2012 Aug 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Molecular Epidemiology*
Influenza A Virus, H1N1 Subtype/*genetics
Influenza, Human/*epidemiology
Glycosylation ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Humans ; Influenza A Virus, H1N1 Subtype/enzymology ; Influenza A Virus, H1N1 Subtype/metabolism ; Influenza, Human/virology ; Neuraminidase/metabolism ; Pakistan/epidemiology ; Phylogeny
Czasopismo naukowe
Tytuł:
Ultrastructural characterization of pandemic (H1N1) 2009 virus.
Autorzy:
Goldsmith CS; Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. />Metcalfe MG
Rollin DC
Shieh WJ
Paddock CD
Xu X
Zaki SR
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2011 Nov; Vol. 17 (11), pp. 2056-9.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza A Virus, H1N1 Subtype/*ultrastructure
Animals ; Biopsy ; Cell Line ; Dogs ; Humans ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Lung/pathology ; Lung/virology ; Virion/ultrastructure
Czasopismo naukowe
Tytuł:
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.
Autorzy:
Garten RJ; WHO Collaborating Center for Influenza, Centers for Disease Control and Prevention (CDC), Atlanta, GA 30333, USA.
Davis CT
Russell CA
Shu B
Lindstrom S
Balish A
Sessions WM
Xu X
Skepner E
Deyde V
Okomo-Adhiambo M
Gubareva L
Barnes J
Smith CB
Emery SL
Hillman MJ
Rivailler P
Smagala J
de Graaf M
Burke DF
Fouchier RA
Pappas C
Alpuche-Aranda CM
López-Gatell H
Olivera H
López I
Myers CA
Faix D
Blair PJ
Yu C
Keene KM
Dotson PD Jr
Boxrud D
Sambol AR
Abid SH
St George K
Bannerman T
Moore AL
Stringer DJ
Blevins P
Demmler-Harrison GJ
Ginsberg M
Kriner P
Waterman S
Smole S
Guevara HF
Belongia EA
Clark PA
Beatrice ST
Donis R
Katz J
Finelli L
Bridges CB
Shaw M
Jernigan DB
Uyeki TM
Smith DJ
Klimov AI
Cox NJ
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2009 Jul 10; Vol. 325 (5937), pp. 197-201. Date of Electronic Publication: 2009 May 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Viral/*immunology
Influenza A Virus, H1N1 Subtype/*genetics
Influenza A Virus, H1N1 Subtype/*immunology
Influenza, Human/*virology
Animals ; Antibodies, Viral/immunology ; Antigens, Viral/genetics ; Disease Outbreaks ; Evolution, Molecular ; Genes, Viral ; Genetic Variation ; Genome, Viral ; Hemagglutination Inhibition Tests ; Hemagglutinin Glycoproteins, Influenza Virus/chemistry ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Humans ; Influenza A Virus, H1N1 Subtype/classification ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza A Virus, H3N2 Subtype/genetics ; Influenza A virus/genetics ; Influenza, Human/epidemiology ; Influenza, Human/immunology ; Mutation ; Neuraminidase/genetics ; Orthomyxoviridae Infections/veterinary ; Orthomyxoviridae Infections/virology ; Phylogeny ; Reassortant Viruses/genetics ; Swine ; Swine Diseases/virology ; Viral Matrix Proteins/genetics ; Viral Nonstructural Proteins/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies